The lipopolysaccharide-triggered mesangial transcriptome: Evaluating the role of interferon regulatory factor-1

Kidney International

Volumn 67, Issue 4, 2005, Pages 1350-1361

  Fu, Yuyang ^b   Xie, Chun ^b   Yan, Mei ^b   Li, Quan ^b   Joh, Jae Won ^b   Lu, Christopher ^b   Mohan, Chandra ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

Chemokines; Glomerulonephritis; Lupus; Mesangial; Microarray

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CHEMOKINE; COLLAGENASE 3; COMPLEMENT COMPONENT C3; CYCLOOXYGENASE 2; DEFENSIN; EPIREGULIN; FRACTALKINE; GAMMA INTERFERON; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERFERON REGULATORY FACTOR 1; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PEPTIDOGLYCAN; PHOSPHOPROTEIN; PLATELET DERIVED GROWTH FACTOR; POLYINOSINIC POLYCYTIDYLIC ACID; SECRETED PHOSPHOPROTEIN 1; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR 2; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTOME; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS; IMMUNE COMPLEX NEPHRITIS; INNATE IMMUNITY; LUPUS ERYTHEMATOSUS NEPHRITIS; MESANGIUM; MESANGIUM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UNINDEXED SEQUENCE;

EID: 16244418059     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00212.x     Document Type: Article

References (42)

1. VEIS JH, YAMASHITA W, LIU YJ, OOI BS: The biology of mesangial cells in glomerulonephritis. Proc Soc Exp Biol Med 195:160-167, 1990
2. HAWKINS NJ, WAKEfiELD D, CHARLESWORTH JA: The role of mesangial cells in glomerular pathology. Pathology 22:24-32, 1990
3. RADEKE HH, RESCH K: The inflammatory function of renal glomerular mesangial cells and their interaction with the cellular immune system. Clin Investigator 70:825-842, 1992
4. XIE C, ZHOU XJ, LIU X, MOHAN C: Enhanced intrinsic susceptibility to renal disease in the lupus facilitating NZW strain. Arthritis Rheum 48:1080-1092, 2003
5. XIE C, SHARMA R, WANG H, et al: Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol 172:5047-5055, 2004
6. STRIKER GE, STRIKER LJ: Glomerular cell culture. Lab Invest 53:122-131, 1985
7. LANG R, PATEL D, MORRIS JJ, et al: Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol 169:2253-2263, 2002
8. SCOTT MG, ROSENBERGER CM, GOLD MR, et al: An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression. J Immunol 165:3358-3365, 2000
9. NAU GJ, RICHMOND JF, SCHLESINGER A, et al: Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci USA 99:1503-1508, 2002
10. GREENWELL-WILD T, VAZOUEZ N, SIM D, et al: Mycobacterium avium infection and modulation of human macrophage gene expression. J Immunol 169:6286-6297, 2002
11. ESKRA L, MATHISON A, SPLITTER G: Microarray analysis of mRNA levels from RAW264.7 macrophages infected with Brucella abortus. Infect Immunol 71:1125-1133, 2003
12. FRENKEL O, SHANI E, BEN-BASSAT I, et al: Activated macrophages for treating skin ulceration: Gene expression in human monocytes after hypo-osmotic shock. Clin Exp Immunol 128:59-66, 2002
13. BUATES S, MATLASHEWSKI G: Identification of genes induced by a macrophage activator, S-28463, using gene expression array analysis. Antimicrob Agents Chemother 45:1137-1142, 2001
14. NAKACHI N, MATSUNAGA K, KLEIN TW, et al: Differential effects of virulent versus avirulent Legionella pneumophila on chemokine gene expression in murine alveolar macrophages determined by cDNA expression array technique. Infect Immunol 68:6069-6072, 2000
15. ROSENBERGER CM, SCOTT MG, GOLD MR, et al: Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression. J Immunol 164:5894-5904, 2000
16. DETWEILER CS, CUNANAN DB, FALKOW S: Host microarray analysis reveals a role for the Salmonella response regulator phoP in human macrophage cell death. Proc Natl Acad Sci USA 98:5850-5855, 2001
17. ANDERS HJ, VIELHAUER V, KRETZLER M, et al: Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis. J Am Soc Nephrol 12:919-931, 2001
18. BANAS B, LUCKOW B, MOLLER M, et al: Chemokine and chemokine receptor expression in a novel human mesangial cell line. J Am Soc Nephrol 10:2314-2322, 1999
19. GRANDE JP, JONES ML, SWENSON CL, et al: Lipopolysaccharide induces monocyte chemoattractant protein production by rat mesangial cells. Lab Clin Med 124:112-117, 1994
20. TESCH GH, SCHWARTING A, KINOSHITA K, et al: Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 103:73, 1999
21. WU X, DOLECKI GJ, LEFKOWITH JB: GRO chemokines: A transduction, integration, and amplification mechanism in acute renal inflammation. Am J Physiol. 269:F248-F256, 1995
22. GUIJARRO C, KIM Y, KASISKE BL, et al: Central role of the transcription factor nuclear factor-kappa B in mesangial cell production of chemokines. Contrib Nephrol 120:210-218, 1997
23. ROVIN BH, DICKERSON JA, TAN LC, et al: Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells. Kidney Int 48:1263-1271, 1995
24. LOPEZ-FRANCO O, SUZUKI Y, SANJUAN G, et al: Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am J Pathol 161:1497-1505, 2002
25. MERIKA M, WILLIAMS AJ, CHEN G, et al: Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol Cell 1:277-287, 1998
26. SAURA M, ZARAGOZA C, BAO C, et al: Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription. J Mol Biol 289:459, 1999
27. MIYAMOTO M, FUJITA T, KIMURA Y, et al: Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 54:903-913, 1988
28. SANCEAU J, BOYD DD, SEIKI M, BAUVOIS B: Interferons inhibit tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-kappa B. Biol Chem 277:35766-35775, 2002
29. OCHI H, MASUDA J, GIMBRONE MA: Hyperosmotic stimuli inhibit VCAM-1 expression in cultured endothelial cells via effects on interferon regulatory factor-1 expression and activity. Eur J Immunol 32:1821-1831, 2002
30. BLANCO JC, CONTURSI C, SALKOWSKI CA, et al: Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression. J Exp Med 191:2131, 2000
31. RADEKE HH, JANSSEN-GRAALFS I, SOWA EN, et al: Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis. J Biol Chem 277:27535-27544, 2002
32. HORA K, SATRIANO JA, SANTIAGO A, et al: Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide 1 and colony-stimulating factor 1. Proc Natl Acad Sci USA 89:1745-1749, 1992
33. HURGIN V, NOVICK D, RUBINSTEIN M: The promoter of IL-18 binding protein: Activation by an IFN-gamma-induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta. Proc Natl Acad Sci USA 99:16957-16962, 2002
34. OETH P, PARRY GC, MACKMAN N: Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arteriosclerosis, Throm Vasc Biol 17:365-374, 1997
35. YE X, LIU SF: Lipopolysaccharide regulates constitutive and inducible transcription factor activities differentially in vivo in the rat. Biochem Biophys Res Comm 288:927-932, 2001
36. SAKUTA T, MATSUSHITA K, YAMAGUCHI N, et al: Enhanced production of vascular endothelial growth factor by human monocytic cells stimulated with endotoxin through transcription factor SP-1. J Med Microbiol 50:233-237, 2001
37. BRIGHTBILL HD, PLEVY SE, MODLIN RL, et al: A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J Immunol 164:1940-1951, 2000
38. HU HM, TIAN Q, BAER M, et al: The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1. J Biol Chem 275:16373-16381, 2000
39. BRADLEY MN, ZHOU L, SMALE ST: C/EBPbeta regulation in lipopolysaccharide-stimulated macrophages. Mol Cell Biol 23:4841-1858, 2003
40. TENGKU-MUHAMMAD TS, HUGHES TR, RANKI H, et al: Differential regulation of macrophage CCAAT-enhancer binding protein isoforms by lipopolysaccharide and cytokines. Cytokine 12:1430-1436, 2000
41. TSAN M-F, GAO B: Endogenous ligands of Toll-like receptors. J Leuko Biol (online publication, 10.1189/jlb.0304127, April 30, 2004)
42. BEG AA: Endogenous ligands of Toll-like receptors: Implications for regulating inflammatory and immune responses. Trends Immunol 23:509-512, 2002